Association of a Single‐Nucleotide Polymorphism in the Pregnane X Receptor (PXR63396C→T) with Reduced Concentrations of Unboosted Atazanavir-Reference-Cited by-同舟云学术

Association of a Single‐Nucleotide Polymorphism in the Pregnane X Receptor (PXR63396C→T) with Reduced Concentrations of Unboosted Atazanavir

Published:2008-11 Issue:9 Volume:47 Page:1222-1225
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Siccardi Marco,D’Avolio Antonio,Baietto Lorena,Gibbons Sara,Sciandra Mauro,Colucci Daniela,Bonora Stefano,Khoo Saye,Back David J.,Perri Giovanni Di,Owen Andrew

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/47/9/1222/1255240/47-9-1222.pdf

Reference20 articles.

1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Departmetn of Health and Human Services. 29 January 2008. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 19 September 2008.

2. Population Pharmacokinetics of Atazanavir in Patients with Human Immunodeficiency Virus Infection

3. Genetic contribution to variable human CYP3A-mediated metabolism

4. Plasma Levels of Atazanavir and the Risk of Hyperbilirubinemia Are Predicted by the 3435C->T Polymorphism at the Multidrug Resistance Gene 1

5. The private sector and HIV/AIDS in Africa: taking stock of 6 years of applied research

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity;Frontiers in Pharmacology;2022-06-16

2. Constitutive androstane receptor and pregnane X receptor genotype influence efavirenz plasma concentration and CYP2B6 enzyme activity;Scientific Reports;2022-06-11

3. Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients;Expert Review of Clinical Pharmacology;2021-11-26

4. Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa;International Journal of Infectious Diseases;2021-03

5. Sources of Interindividual Variability;Methods in Molecular Biology;2021